These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38545024)
1. Clinical utility of CLL-IPI scoring system in Pakistani Chronic Lymphocytic Patients: A single center experience. Hameed A; Sajid N; Fayyaz M; Khaliq S Pak J Med Sci; 2024; 40(4):701-705. PubMed ID: 38545024 [TBL] [Abstract][Full Text] [Related]
2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia]. Zhu HY; Wang L; Qiao J; Zou YX; Xia Y; Wu W; Cao L; Liang JH; Fan L; Xu W; Li JY Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):392-397. PubMed ID: 29779348 [No Abstract] [Full Text] [Related]
4. Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies. Langerbeins P; Giza A; Robrecht S; Cramer P; von Tresckow J; Al-Sawaf O; Fink AM; Fürstenau M; Kutsch N; Simon F; Goede V; Hoechstetter M; Niemann CU; da Cunha-Bang C; Kater A; Dubois J; Gregor M; Staber PB; Tausch E; Schneider C; Stilgenbauer S; Eichhorst B; Fischer K; Hallek M Blood; 2024 Jun; 143(25):2588-2598. PubMed ID: 38620092 [TBL] [Abstract][Full Text] [Related]
5. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. International CLL-IPI working group Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642 [TBL] [Abstract][Full Text] [Related]
6. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients. Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919 [TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort. Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the CLL-IPI and IPS-E Prognostic Indices in a Young Middle Eastern Population with Chronic Lymphocytic Leukemia: A Retrospective Analysis at the Kuwait Cancer Control Center. Alshemmari SH; Alsarraf A; Kunhikrishnan A; Pandita R Med Princ Pract; 2023; 32(3):192-199. PubMed ID: 37517397 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients]. Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923 [No Abstract] [Full Text] [Related]
10. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Soumerai JD; Ni A; Xing G; Huang J; Furman RR; Jones J; Sharman JP; Hallek M; Adewoye AH; Dubowy R; Dreiling L; Zelenetz AD Leuk Lymphoma; 2019 Jun; 60(6):1438-1446. PubMed ID: 30407886 [TBL] [Abstract][Full Text] [Related]
11. [Clinical Characteristics and Long-Term Survival of Patients with Chronic Lymphocytic Leukemia]. Ma L; Li Y; Wang JJ; Jing HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(5):1345-1351. PubMed ID: 37846683 [TBL] [Abstract][Full Text] [Related]
12. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228 [TBL] [Abstract][Full Text] [Related]
13. Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests. Meiseles A; Paley D; Ziv M; Hadid Y; Rokach L; Tadmor T Comput Biol Med; 2022 Jun; 145():105490. PubMed ID: 35405402 [TBL] [Abstract][Full Text] [Related]
14. Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia. Giudice V; Serio B; Bertolini A; Mettivier L; D'Alto F; Pezzullo L; D'Addona M; Fumo R; Zeppa P; Gorrese M; Selleri C Eur J Haematol; 2022 Nov; 109(5):483-493. PubMed ID: 35871396 [TBL] [Abstract][Full Text] [Related]
15. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia. Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403 [TBL] [Abstract][Full Text] [Related]
16. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index. Muñoz-Novas C; Poza-Santaella M; González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Infante MS; Heras C; Foncillas MÁ; Marín K; Hernández-Rivas JM; Hernández JÁ Biomed Res Int; 2018; 2018():9506979. PubMed ID: 29736400 [TBL] [Abstract][Full Text] [Related]
17. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia. Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W Front Immunol; 2022; 13():962000. PubMed ID: 36275721 [TBL] [Abstract][Full Text] [Related]
18. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. Kleinstern G; O'Brien DR; Li X; Tian S; Kabat BF; Rabe KG; Norman AD; Yan H; Vachon CM; Boddicker NJ; Call TG; Parikh SA; Bruins L; Bonolo de Campos C; Leis JF; Shanafelt TD; Ding W; Cerhan JR; Kay NE; Slager SL; Braggio E Am J Hematol; 2020 Aug; 95(8):906-917. PubMed ID: 32279347 [TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419 [TBL] [Abstract][Full Text] [Related]
20. A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels. Kim HD; Cho H; Jeong H; Bang K; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Oh SY; Suh C Br J Haematol; 2021 Apr; 193(2):307-315. PubMed ID: 33216979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]